Day 2 ASH: Transplant is still a promising treatment, but MRD is King

Jack Aiello |

Today began with watching ASH abstract presentations from yesterday.  This is actually one of the benefits of attending the meeting virtually. Presentations are often scheduled at the same time and at the in-person meeting, you need to make a decision which to attend.  But being virtual, I’m able to watch a replay of a session […]

How Virtual #ASH20 is Going and much more!

Yelak Biru |

The International Myeloma Foundation Social Media team has been active even though this year’s American Society of Hematology meeting is taking place virtually. Not only attending session virtually and engaging with researchers, clinicians, pharmaceutical representatives, and others; but also, coming together for virtual debriefs and virtual recharge. I miss seeing these myeloma friends in person, […]

Twenty-five – Twenty-five

Yelak Biru |

When I was diagnosed with myeloma at age 25 and was told “You have myeloma. It is incurable but it is highly treatable. Come to my office tomorrow, and we will discuss your options.”  And when, soon after that, I was told the life expectancy of myeloma patients is 2-3 years. Or, with outstanding response […]